期刊文献+

Therapeutic potential role of exosomes for ischemic stroke 被引量:2

Therapeutic potential role of exosomes for ischemic stroke
原文传递
导出
摘要 Exosomes are extracellular vesicles with a diameter of 30–100 nm,which are released into the extracellular space by fusion of multivesicular and plasma membranes.These vesicles actually play a distinct role in cell communication,although they were considered as membrane debris in the past.The endosomal sorting complex required for transport(ESCRT)-dependent and ESCRT-independent mechanisms are currently considered to be involved in the sorting of exosomes,and the release of exosomes is related to the members of Rab protein family and SNARE family.In recent years,the therapeutic potential of exosomes has become apparent.For example,via the direct transplantation of exosomes,the ischemic area after stroke is reduced,and the neurological function is improved significantly.Furthermore,they can be used as effective drug delivery vehicles due to their unique characteristics such as low immunogenicity and nanometer size.In conclusion,exosomes provide a cell-free treatment for ischemic stroke. Exosomes are extracellular vesicles with a diameter of 30–100 nm, which are released into the extracellular space by fusion of multivesicular and plasma membranes. These vesicles actually play a distinct role in cell communication, although they were considered as membrane debris in the past. The endosomal sorting complex required for transport(ESCRT)-dependent and ESCRT-independent mechanisms are currently considered to be involved in the sorting of exosomes, and the release of exosomes is related to the members of Rab protein family and SNARE family. In recent years, the therapeutic potential of exosomes has become apparent. For example, via the direct transplantation of exosomes, the ischemic area after stroke is reduced, and the neurological function is improved significantly. Furthermore, they can be used as effective drug delivery vehicles due to their unique characteristics such as low immunogenicity and nanometer size. In conclusion, exosomes provide a cell-free treatment for ischemic stroke.
出处 《Brain Science Advances》 2019年第2期128-143,共16页 神经科学(英文)
基金 supported by the National Natural Science Foundation of China(No.81671819).
关键词 EXOSOMES BIOLOGY BIOGENESIS THERAPY exosomes biology biogenesis therapy
  • 相关文献

参考文献3

二级参考文献79

  • 1Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, MathersC, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012.v1.0,Cancer incidence and mortality worldwide: IARC CancerBaseNo. 11[Internet]. Lyon, France: International Agency for Researchon Cancer, 2013. Available from: URL: http: //globocan.iarc.fr.
  • 2Kaur G, Dufour JM. Cell lines: Valuable tools or useless artifacts.Spermatogenesis 2012; 2: 1-5 [PMID: 22553484 DOI: 10.4161/spmg.19885].
  • 3Sandberg R, Ernberg I. Assessment of tumor characteristic geneexpression in cell lines using a tissue similarity index (TSI). ProcNatl Acad Sci USA 2005; 102: 2052-2057 [PMID: 15671165 DOI:10.1073/pnas.0408105102].
  • 4Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K,Sivachenko A, Carter SL, Stewart C, Mermel CH, Roberts SA,Kiezun A, Hammerman PS, McKenna A, Drier Y, Zou L, RamosAH, Pugh TJ, Stransky N, Helman E, Kim J, Sougnez C, AmbrogioL, Nickerson E, Shefler E, Cortés ML, Auclair D, Saksena G, VoetD, Noble M, DiCara D, Lin P, Lichtenstein L, Heiman DI, FennellT, Imielinski M, Hernandez B, Hodis E, Baca S, Dulak AM, LohrJ, Landau DA, Wu CJ, Melendez-Zajgla J, Hidalgo-Miranda A,Koren A, McCarroll SA, Mora J, Lee RS, Crompton B, Onofrio R,Parkin M, Winckler W, Ardlie K, Gabriel SB, Roberts CW, BiegelJA, Stegmaier K, Bass AJ, Garraway LA, Meyerson M, GolubTR, Gordenin DA, Sunyaev S, Lander ES, Getz G. Mutationalheterogeneity in cancer and the search for new cancer-associatedgenes. Nature 2013; 499: 214-218 [PMID: 23770567 DOI: 10.1038/nature12213].
  • 5Meacham CE, Morrison SJ. Tumour heterogeneity and cancercell plasticity. Nature 2013; 501: 328-337 [PMID: 24048065 DOI:10.1038/nature12624].
  • 6Rangarajan A, Weinberg RA. Opinion: Comparative biology ofmouse versus human cells: modelling human cancer in mice. NatRev Cancer 2003; 3: 952-959 [PMID: 14737125].
  • 7Collins AT, Habib FK, Maitland NJ, Neal DE. Identificationand isolation of human prostate epithelial stem cells basedon alpha(2)beta(1)-integrin expression. J Cell Sci 2001; 114:3865-3872 [PMID: 11719553].
  • 8Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA,Swiergiel JJ, Marshall VS, Jones JM. Embryonic stem cell linesderived from human blastocysts. Science 1998; 282: 1145-1147[PMID: 9804556 DOI: 10.1126/science.282.5391.1145].
  • 9Takahashi K, Yamanaka S. Induction of pluripotent stem cellsfrom mouse embryonic and adult fibroblast cultures by definedfactors. Cell 2006; 126: 663-676 [PMID: 16904174 DOI: 10.1016/j.cell.2006.07.024].
  • 10Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, TomodaK, Yamanaka S. Induction of pluripotent stem cells from adulthuman fibroblasts by defined factors. Cell 2007; 131: 861-872[PMID: 18035408 DOI: 10.1016/j.cell.2007.11.019].

共引文献121

同被引文献9

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部